Aptamer-conjugated polymeric nanoparticles for targeted cancer therapy

Drug Delivery and Translational Research
Athulya AravindD Sakthi Kumar

Abstract

Recent advances in cancer nanotechnology have led to the emergence of aptamer-enabled technologies to diagnose and treat cancer. Aptamers with their high binding sensitivity and specificity are highly attractive for a wide variety of applications in molecular targeting. Aptamer-escorted drug-loaded polymeric nanoparticles represent a promising technology, which facilitates controlled release and targeted approach to deliver drugs to the desired site with marginal or any collateral damage. By properly integrating these nanobased approaches with the established cancer research findings could help to resolve some of the existing problems in the current conventional cancer therapy. In this review, we discuss the progresses achieved in the aptamer mediated nanoparticle drug delivery and properties of nanoparticles, which play a significant role in developing the aptamer-nanoparticle bioconjugates. In addition, we highlight the recent preclinical works involving these bioconjugates as cancer therapeutics.

References

Aug 30, 1990·Nature·A D Ellington, J W Szostak
Apr 1, 1994·Analytical Biochemistry·D Sehgal, I K Vijay
Mar 18, 1994·Science·R GrefR Langer
Jan 1, 1996·Methods in Enzymology·T Fitzwater, B Polisky
Nov 12, 1996·Biochemistry·L S GreenN Janjic
Mar 31, 1998·Journal of Pharmaceutical Sciences·J GaoR Langer
May 16, 1998·Proceedings of the National Academy of Sciences of the United States of America·S K HobbsR K Jain
Jul 17, 1998·Experimental Cell Research·M KovalT H Steinberg
Jun 1, 1997·Current Opinion in Chemical Biology·S E OsborneA D Ellington
Sep 15, 1998·Bioconjugate Chemistry·M C WillisB Collins
Oct 12, 1999·Journal of Chromatography. B, Biomedical Sciences and Applications·C E TuckerD W Drolet
Feb 10, 2000·Annals of the New York Academy of Sciences·K HongD Papahadjopoulos
Feb 12, 2000·Journal of Microencapsulation·P SommerfeldU Schroeder
Mar 4, 2000·Journal of Controlled Release : Official Journal of the Controlled Release Society·H MaedaK Hori
May 29, 2000·Biochimica Et Biophysica Acta·D E Lopes de MenezesT M Allen
Jun 6, 2000·Advanced Drug Delivery Reviews·M S Shive, J M Anderson
Sep 23, 2000·Nature·P Carmeliet, R K Jain
Oct 18, 2000·The Journal of Clinical Investigation·B J Hicke, A W Stephens
Oct 18, 2000·The Journal of Clinical Investigation·R R WhiteC P Rusconi
Oct 18, 2000·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·R Krishna, L D Mayer
Feb 17, 2001·Biochemical and Biophysical Research Communications·S JeongJ Yu
Aug 8, 2001·Journal of Controlled Release : Official Journal of the Controlled Release Society·R K Jain
Aug 11, 2001·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Beverly A. Teicher
Oct 9, 2001·The Journal of Biological Chemistry·B J HickeS Warren
Apr 1, 1997·Chemical Reviews·Scott E. Osborne, Andrew D. Ellington
Feb 21, 2002·Journal of Controlled Release : Official Journal of the Controlled Release Society·K AvgoustakisD S Ithakissios
Mar 19, 2002·International Journal of Pharmaceutics·Jasmine Davda, Vinod Labhasetwar

❮ Previous
Next ❯

Citations

Aug 27, 2015·Life·Ádám Kun, Eörs Szathmáry
Aug 27, 2016·Cellular and Molecular Life Sciences : CMLS·Jing QuJianliang Zhang
Mar 20, 2014·Chemical Society Reviews·M MontaltiN Zaccheroni
Mar 29, 2019·Chemical Biology & Drug Design·Anurag Pramanik, Sanjeev Garg

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Susana Patricia EgusquiaguirreJosé Luis Pedraz
Cancer Research and Treatment : Official Journal of Korean Cancer Association
Xu WangDong M Shin
© 2021 Meta ULC. All rights reserved